Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02857374 · ClinicalTrials.gov registry record · NA
Intravital Microscopy in Identifying Tumor Vessels in Patients With Stage IB-IIIC Melanoma Undergoing Sentinel Lymph Node Biopsy
A NA study, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02857374 is a NA study that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 20 participants.
The verdict
NCT02857374, a NA study, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This pilot clinical trial studies intravital microscopy in identifying tumor vessels in patients with stage IB-IIIC melanoma undergoing sentinel lymph node biopsy. By examining sentinel lymph nodes through intravital microscopy before they are removed, doctors may learn specific information regarding how melanoma may spread to lymph nodes and other sites of the body.
Interventions
- OTHER Laboratory Biomarker Analysis
- PROCEDURE Sentinel Lymph Node Biopsy
- DRUG Fluorescein Sodium Injection
- PROCEDURE Diagnostic Microscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-11-03 |
| Est. Completion | 2022-06-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02857374
The ClinicalTrials.gov registry entry for NCT02857374 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT02857374 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02857374 about?
NCT02857374 is a clinical study titled "Intravital Microscopy in Identifying Tumor Vessels in Patients With Stage IB-IIIC Melanoma Undergoing Sentinel Lymph Node Biopsy". This pilot clinical trial studies intravital microscopy in identifying tumor vessels in patients with stage IB-IIIC melanoma undergoing sentinel lymph node biopsy. By examining sentinel lymph nodes through intravital microscopy before they are removed, doctors may learn specific information regardin...
What is the current status of trial NCT02857374?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2016-11-03. Estimated completion is 2022-06-13.
What interventions are being tested in trial NCT02857374?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Sentinel Lymph Node Biopsy (PROCEDURE), Fluorescein Sodium Injection (DRUG), Diagnostic Microscopy (PROCEDURE).
Who is sponsoring clinical trial NCT02857374?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.